Loading insider details...
Latest Form 4 (Oct 28, 2026): Conversion of 5,631,425 LYCA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 28, 2026 | Lycia Therapeutics, Inc. (LYCA) | Conversion | 5,631,425 | n/a |
| Oct 2, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 49,701 | $2.25M |
| Sep 22, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 49,479 | $2.06M |
| Aug 26, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 20,493 | $820.3K |
| Aug 19, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 145,051 | $5.73M |
| Jul 14, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 191,376 | $6.51M |
| Jul 1, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 200,000 | $6.09M |
| Jun 20, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 100,000 | $3.00M |
| Jun 12, 2025 | LENZ Therapeutics, Inc. (LENZ) | Sale | 350,000 | $10.15M |
| Mar 25, 2024 | LENZ Therapeutics, Inc. (LENZ) | Other (see footnotes) | 598,203 | n/a |